Zambon Group
AI Trust Score, Reviews & Company Verification
Legal nameZambon Group
- Risk: Low
- Not Claimed
This profile is waiting for Zambon Group
Zambon Group has not claimed this ShouldEye profile yet.
Until an authorized representative verifies ownership, ShouldEye AI independently maintains this overview from public records, reviews, regulatory filings, and live trust signals. Nothing on this page has been approved by the brand.
- Respond to reviews and experiences in your voice
- Replace this placeholder with your official brand message
- Take control of how your trust score is presented
Free verification for authorized company representatives
Zambon Group is an Italian family‑owned pharmaceutical and fine‑chemical company that develops and produces medicines, focusing on therapeutic areas such as respiratory, pain relief and women's health. Founded in 1906, the group emphasizes quality and research & development.
- Headquarters
- US
Full intelligence report for Zambon Group
Zambon Group operates with strong accountability across consumer-facing dimensions, showing particular strength in privacy protection, regulatory compliance, and customer satisfaction, all of which suggest a company that prioritizes transparent and secure interactions. Its legal and domain integrity practices, while still solid, lag modestly behind its other signals, indicating room for incremental improvement in disclosure and digital footprint consistency despite an overall verified, high-trust posture.
- Comprehensive compliance framework including a Code of Ethics, Anti‑Corruption Policy, Whistleblowing system and adherence to Italian Legislative Decree 231/2001.
- Manufacturing plants certified to current Good Manufacturing Practice (cGMP) and holding FDA approval, with no FDA Form 483 observations from 2010‑2017.
- Active membership in Farmindustria and compliance with its Disclosure Code.
- Received an FDA Pre‑Notice Letter (dated 28‑Aug‑2025) indicating potential non‑compliance in a clinical trial.
- Involved in ongoing patent litigation as a plaintiff and reporting increased legal expenses, indicating active legal exposure.
- Potential for name confusion with unrelated individuals named Zambon, which could affect reputation.
Public-facing leadership and ownership signals for Zambon Group — synthesized from verified profiles and corporate disclosures where available.